Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | LA |
Development of pain and redness at injection site; Development of pain and redness at injection site; Development of vasculitis/dermatitis on both legs; Development of vasculitis/dermatitis on both legs; This is a spontaneous report received from a Consumer or other non HCP. A 45-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 20May2025 as dose number unknown, single (Batch/Lot number: unknown) at the age of 45 years, in left arm for immunisation. The patient's relevant medical history included: "Lupus SLE" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Allergy to shellfish" (unspecified if ongoing). Concomitant medication(s) included: PREDNISONE, start date: 14May2025; COLCHICINE, start date: 12Feb2025. The following information was reported: VACCINATION SITE PAIN (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 22May2025, outcome "recovering" and all described as "Development of pain and redness at injection site"; DERMATITIS (non-serious), VASCULITIS (non-serious) all with onset 22May2025, outcome "recovering" and all described as "Development of vasculitis/dermatitis on both legs". Therapeutic measures were taken as a result of dermatitis, vasculitis including the use of steroid ointment for legs. Additional information: Development of pain and redness at injection site that persists over 1 week. Development of vasculitis/dermatitis on both legs 2 days after administration. The patient did not receive any other vaccines on the same date as the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Hypertension; Shellfish allergy; SLE
PREDNISONE; COLCHICINE